STAGE III ADULT HODGKIN LYMPHOMA
Clinical trials for STAGE III ADULT HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE III ADULT HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for STAGE III ADULT HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for older hodgkin lymphoma patients
Disease control CompletedThis phase II trial tested a combination of the targeted drug brentuximab vedotin with standard chemotherapy (AVD) in 49 older adults with untreated Hodgkin lymphoma. The goal was to see if this approach could improve the number of patients whose cancer completely disappears. The…
Matched conditions: STAGE III ADULT HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
New combo shows promise against tough lymphomas
Disease control CompletedThis study tested a combination of the drug lenalidomide with standard chemotherapy (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the safest dose and see how well the treatment controls the cancer. Results help guide future t…
Matched conditions: STAGE III ADULT HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC